The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.
Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-L...
Guardado en:
Autores principales: | Nicolas Dzamko, Francisco Inesta-Vaquera, Jiazhen Zhang, Chengsong Xie, Huaibin Cai, Simon Arthur, Li Tan, Hwanguen Choi, Nathanael Gray, Philip Cohen, Patrick Pedrioli, Kristopher Clark, Dario R Alessi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc7785f27b4c46faa025687a64c79f6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
por: Virginie Ropars, et al.
Publicado: (2009) -
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011) -
Acta Nº935
por: Banco Central de Chile
Publicado: (2019) -
Massive autophosphorylation of the Ser/Thr-rich domain controls protein kinase activity of TRPM6 and TRPM7.
por: Kristopher Clark, et al.
Publicado: (2008) -
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
por: Eun-Jin Bae, et al.
Publicado: (2018)